Tel: 81-6-6231-6146

Email: [email protected]

United States
EN
Cat. No. Size / Unit Price Qty
CS-W001157 4
Total: USD 88.00

Pharmaceutical Development and Drug Discovery Research Reagents

Pharmaceutical Development and Drug Discovery Research Reagents refer to various chemical reagents, molecular building blocks and biological materials used in the drug discovery and development process. These reagents play a key role in different stages of research, helping scientists to conduct experiments, screen and optimize potential drugs. ChemScene has a variety of molecular building blocks and other reagents to support the drug discovery and development process, designed to accelerate your drug research process.

Pharmaceutical Development and Drug Discovery Research Reagents

Pharmaceutical Development and Drug Discovery Research Reagents refer to various chemical reagents, molecular building blocks and biological materials used in the drug discovery and development process. These reagents play a key role in different stages of research, helping scientists to conduct experiments, screen and optimize potential drugs. ChemScene has a variety of molecular building blocks and other reagents to support the drug discovery and development process, designed to accelerate your drug research process.

Drug Delivery Systems (DDS)

Drug delivery system refers to a technical system that comprehensively regulates the distribution of drugs in the body in terms of space, time and dosage. It improves the health of patients by enhancing the delivery of therapeutic drugs to their target sites and minimizing accumulation outside the target. Compared with traditional drug delivery systems based on conventional oral tablets, capsules, intravenous injections, inhalation preparations and transdermal patches, new drug delivery systems refer to systems that use new drug delivery technologies with overall high technical barriers (such as drug delivery technologies based on liposomes, nanoparticles, microspheres, exosomes, engineered AAV vectors, 3D printed drug preparations, etc.) to deliver various types of drugs. New drug delivery systems can improve the efficacy of drugs and reduce toxic side effects by adjusting the delivery and release sites of drugs, changing the metabolic behavior of drugs in the body, improving the sustained-release and controlled-release properties of drugs, and the properties of penetrating physiological barriers (such as the blood-brain barrier).

Nucleic Acid Chemistry

Nucleic acid chemistry covers a series of processes such as the synthesis, modification, mutation, and degradation of DNA and RNA. These chemical reactions are the basis of information transmission and expression regulation in life. With the development of molecular biology technology, nucleic acid chemistry has become increasingly important in diseases. Its applications in the fields of therapy, genetic engineering, molecular diagnosis, etc. are becoming increasingly extensive, showing important scientific and clinical value.

Peptide Chemistry

Peptides are widely present in nature and in living organisms. They are a type of natural substance composed of two or more amino acids connected by peptide bonds. They are also the product of incomplete hydrolysis of proteins. So far, a wide variety of peptides have been found in organisms, and they play an important role in participating in and regulating life activities in the body. According to the number of amino acids, they can be divided into oligopeptides (2-1 amino acids) and polypeptides (1-1 amino acids).

PEGylation

Polyethylene glycol (PEG), also known as polyethylene oxide (PEO) or polyoxyethylene (POE), refers to oligomers or polymers of ethylene oxide. Polyethylene glycol has excellent lubricity, moisturizing and dispersibility, and can be used as a softener and antistatic agent. It is widely used in cosmetics, pharmaceuticals, chemical fibers, rubber, plastics, papermaking, paints, electroplating, pesticides, metal processing and food processing industries.

Linkers and Crosslinkers

Cross-linkers are molecules with two or more reactive ends that can be chemically linked to specific functional groups (primary amines, sulfhydryls, etc.) on proteins or other molecules. This technique, often referred to as bioconjugation when used with proteins and other biomolecules, is an important component of many proteomics methods, including the creation of detectable probes for western blotting and ELISA, as well as strategies to study protein structure and interactions.

Specialized Building Blocks for Drug Discovery

Specialized Building Blocks for Drug Discovery refer to tools and frameworks designed and optimized specifically for the drug discovery process.

Antibody-Drug Conjugates (ADC) Preparation Research Reagents

ADC drugs are targeted drugs formed by coupling monoclonal antibodies with small molecule toxin drugs through linkers. ADC consists of three parts: antibodies, small molecule toxins and linkers. Each component needs to have corresponding characteristics. The antibody needs to have high specificity and low immunogenicity; the linker needs to be stable in the circulatory system and can effectively release cytotoxins in the tumor environment, and the small molecule toxin needs to be stable under physiological conditions and have strong lethality to tumor cells; the ideal ADC drug needs to remain stable in the blood circulation, accurately reach the treatment target, and ultimately release cytotoxicity near the target.

Building Blocks for Pharmaceutical Ingredients

Drug building blocks are a class of basic units used to synthesize complex compounds with specific activities. They usually have active functional groups and can be used for the "bottom-up" assembly of characteristic molecular structures. In the process of new drug research and development, drug building blocks are widely used in key links such as drug target discovery, screening and optimization of lead compounds and lead compounds, and determination of clinical candidates.

Proteolysis Targeting Chimera Research Reagents

PROTACs consist of a small molecule ligand that binds to a target protein and brings it into proximity with an E3 ubiquitin ligase, resulting in its ubiquitination and subsequent degradation by the proteasome machinery. These research reagents are used to study protein function, discover new drug targets , and develop novel therapeutic strategies for diseases such as cancer and neurodegenerative disorders.

This product is not sold in the region.
Confirm